InvestorsHub Logo
Followers 155
Posts 2695
Boards Moderated 0
Alias Born 01/29/2004

Re: Steady_T post# 405292

Wednesday, 03/01/2023 10:48:57 AM

Wednesday, March 01, 2023 10:48:57 AM

Post# of 473884
Good things will be discovered, first.

There is tantalizing data that suggests that 2-73 may have a positive effect on a multitude of indications in a wide range of areas not just CNS indications. It's going to take a lot of trials to prove that.


But, before that, before new clinical trials with other CNS indications would occur, it will be discovered anecdotally that the blarcamesine successfully treats or prevents not only the particular debility for which it was prescribed, but in those individuals taking the drug it renders additional medical improvements. It will become clearly obvious that blarcamesine fixes not only the specific disease it's being prescribed for, but it also, concomitantly, improves other health problems.

It is able to produce these favorable broad therapeutic outcomes because it uniquely acts, restores cellular processes "upstream," at their start, with consequent downstream processes then working properly.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News